NYSE:WEIWeidai Stock Price, Forecast & News

Weidai's stock was trading at $1.46 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, WEI stock has increased by 11.0% and is now trading at $1.62. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Weidai in the last year. There are currently 2 sell ratings for the stock, resulting in a consensus recommendation of "Sell." View analyst ratings for Weidai.

Weidai Ltd (NYSE:WEI) announced its earnings results on Wednesday, May, 27th. The company reported ($1.14) earnings per share (EPS) for the quarter, missing the consensus estimate of $1.55 by $2.69. The business earned $101.54 million during the quarter. Weidai had a return on equity of 7.24% and a net margin of 7.55%. View Weidai's earnings history.

2 analysts have issued 12 month price targets for Weidai's stock. Their forecasts range from $5.40 to $5.40. On average, they anticipate Weidai's stock price to reach $5.40 in the next twelve months. This suggests a possible upside of 233.3% from the stock's current price. View analysts' price targets for Weidai.

Media coverage about WEI stock has been trending negative on Thursday, InfoTrie reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Weidai earned a news sentiment score of -2.6 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutWeidai.

Some companies that are related to Weidai include Qudian (QD), Yirendai (YRD), Curo Group (CURO), Oportun Financial (OPRT), America First Multifamily Investors (ATAX), CNFinance (CNF), X Financial (XYF), Wins Finance (WINS), Jiayin Group (JFIN), Security National Financial (SNFCA), Elevate Credit (ELVT), Consumer Portfolio Services (CPSS), Medallion Financial (MFIN), Hexindai (HX) and On Deck Capital (ONDK). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Weidai investors own include AbbVie (ABBV), Energy Transfer LP Unit (ET), Netflix (NFLX), Ovid Therapeutics (OVID), Primo Water (PRMW), Voyager Therapeutics (VYGR), American Airlines Group (AAL), Baidu (BIDU), Carnival (CCL) and Corbus Pharmaceuticals (CRBP).

(WEI) raised $45 million in an initial public offering on Thursday, November 15th 2018. The company issued 4,500,000 shares at $9.00-$11.00 per share. Morgan Stanley and Citigroup served as the underwriters for the IPO and AMTD was co-manager.

Weidai trades on the New York Stock Exchange (NYSE) under the ticker symbol "WEI."

Shares of WEI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of WEI stock can currently be purchased for approximately $1.62.

Weidai has a market capitalization of $114.12 million and generates $482.27 million in revenue each year. The company earns $36.43 million in net income (profit) each year or $0.52 on an earnings per share basis. Weidai employs 9,919 workers across the globe.

The official website for Weidai is www.weidai.com.cn.

Weidai's mailing address is 50F WEST BUILDING FORTUNE FINANCE CENTER NO.33 JIEFANG EAST ROAD JIANGGAN DISTRI, HANGZHOU F4, 310000. The company can be reached via phone at 86-185-0164-1666 or via email at [email protected]